News

Oslo, 25 March 2026 – Observe Medical ASA (the "Company" or "Observe Medical") announces that its journey into the strategically important Indian market has reached a new level through the signing of an exclusive distribution agreement with a leading local partner. This replaces the previously announced LOI. The partner is a historical distributor of UnoMeter™ and…

Oslo, 25 March 2026. With reference to today's webcast, please find enclosed the presentation. Key topics: · 80% growth in quarterly sales LTM · Commercial launch of UnoMeter™ Safeti Max · Extended product offering to our distributors, capitalizing on the UnoMeter brand position · Sales in 46 countries  · Current addressable market value grown from…

Oslo, 4 March, 2026 – Observe Medical ASA (the "Company" or "Observe Medical") announces initiatives to reduce complexity and cost to invest further in growth. Innovation Norway financing The Company has received a NOK 15 million loan from Innovation Norway. The loan has been disbursed and strengthens the Company’s cash position and supports continued development of…

Oslo, February 27, 2026 – Observe Medical ("the Company" or "Observe Medical") today releases its results for the second half and the full year of 2025. Highlights · Revenue growth: UnoMeter™ portfolio revenues of NOK 7.5 million in the second half, representing an increase of 69% from the same period in 2024. For the full year…

Oslo, 11 February 2025 – Observe Medical ASA (the "Company" or "Observe Medical") announces entry into the Indian market with LOI signed with strong local partner and first order received. India represents one of the largest and fastest-growing healthcare markets worldwide and is projected to grow at a compound annual growth rate (CAGR) of 15–18%,…

Oslo, 19 December 2025 – Observe Medical ASA (the "Company" or "Observe Medical", OSE ticker "OBSRV") has received a loan commitment from Innovation Norway for a loan of NOK 15 million to support the continued commercialisation of the Company’s UnoMeter™ product portfolio, and commercial preparation for the launch of Sippi®. The availability of the loan is…

Oslo, 12 December 2025 – Observe Medical ASA (the "Company" or "Observe Medical") announces expansion of portfolio, progress on commercial journey and in the development of UnoMeter™ Safeti™ Max. The Company is launching an extension of its portfolio of products within the category of Urological Drainage. The launch includes 3 new products: a front mounted…

Oslo, 22 October 2025: Observe Medical ASA (the "Company") has been informed that Glimt Invest AS, a close associate to Terje Bakken, chairman of the board and primary insider of the Company, has purchased 30,000 shares in the Company as further specified in the attached notification form. This information is subject to the disclosure requirements…

Oslo, 20 October 2025 Reference is made to the announcement by Observe Medical ASA (the "Company" or "Observe Medical", OSE ticker "OBSVR") on 13 October 2025 regarding the final result of the subsequent offering in the Company, where a total of 24,000,000 new shares were subscribed and allocated at a subscription price of NOK 0.50…

Oslo, 16 October 2025 Reference is made to the announcement by Observe Medical ASA (the "Company" or "Observe Medical", OSE ticker "OBSVR") on 10 October 2025 regarding the extraordinary general meeting's resolution to increase the share capital of the Company by the issuance of 20,000,000 new shares to Songa Capital AS and four affiliated companies in…

Oslo, 14 October 2025: Observe Medical ASA (the "Company") has been informed that Glimt Invest AS, a close associate to Terje Bakken, chairman of the board and primary insider of the Company, has purchased 425,000 shares in the Company as further specified in the attached notification form. Following the purchase Glimt Invest AS holds 2,775,000…

*Correction: The preliminary count of received subscriptions indicates that 30,159,322 Offer Shares have been subscribed for. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, HONG KONG, JAPAN, THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT…

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, HONG KONG, JAPAN, THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Oslo, 10 October 2025…

Oslo, 10 October 2025 Reference is made to the stock exchange announcement by Observe Medical ASA ("Observe Medical" or the "Company", OSE ticker: OBSVR)) on 19 September 2025, regarding notice of an extraordinary general meeting in connection with a private placement to be carried out pursuant to an investment agreement entered into with Songa Capital…

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, HONG KONG, JAPAN, THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Oslo, 10 October 2025…

Oslo, 7 October 2025. With reference to today's webcast, please find enclosed the presentation, also made available at https://observemedical.com/. A recording of the presentation is also available at: Hegnar Media – Observe Medical Trading update 7 october 2025 (https://channel.royalcast.com/hegnarmedia/#!/hegnarmedia/20251007_1) For further information, please contact: Jørgen Mann, CEO Observe Medical Mobile: +45 408 67 558 E-mail: jorgen.mann@observemedical.com Johan Fagerli, CFO…

Oslo, 6 October 2025 Reference is made to the announcement by Observe Medical ASA (the "Company, OSE ticker "OBSVR") on 25 September 2025 regarding the launch of the subsequent offering of up to 24,000,000 new shares in the Company (the "Subsequent Offering"). The following primary insider has today subscribed for offer shares in the Subsequent…

Oslo, 25 September 2025 – Observe Medical ASA (the "Company" or "Observe Medical") announces further progress in the Italian market. The Company’s distributor in Italy has secured a public tender to supply UnoMeter™ products into the largest region in Italy, corresponding to an estimated olume of approximately 240,000 units annually for a period of three…

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, HONG KONG, JAPAN, THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Oslo, 25 September 2025…

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, HONG KONG, JAPAN, THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Oslo, 24 September 2025…